NCT05223114View on ClinicalTrials.gov

Airway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan Cohort

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
COPDHIV InfectionsRespiratory Disease
Interventions
OTHER

Not applicable (N/A)

Not applicable to this study

Trial Locations (1)

256

Makerere University Lung Institute, Kampala

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

lead

Makerere University

OTHER